Invention Grant
- Patent Title: Vaccination against host cell-associated herpes viruses
- Patent Title (中): 针对宿主细胞相关性疱疹病毒的疫苗接种
-
Application No.: US10354932Application Date: 2003-01-30
-
Publication No.: US09073979B2Publication Date: 2015-07-07
- Inventor: Frank Fehler , Klaus Osterrieder
- Applicant: Frank Fehler , Klaus Osterrieder
- Applicant Address: US IN Indianapolis
- Assignee: Lohmann Animal Health GmbH
- Current Assignee: Lohmann Animal Health GmbH
- Current Assignee Address: US IN Indianapolis
- Agent David L. Pflugh
- Priority: EP00202757 20000803
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61K39/245 ; C12P21/06 ; C12N15/00 ; C12N15/09 ; C12N15/63 ; C12N15/74 ; C12N15/70 ; C07K14/005 ; A61K39/00
Abstract:
The invention relates to the field of so-called “host cell-associated herpes viruses,” such as Marek's disease-like virus (MDV) of poultry and Varicella Zoster virus (VZV) of man, and to vaccination against disease caused by these viruses. The invention provides a vaccine directed against an infection caused by a herpes virus that is essentially host cell-associated comprising a recombinant viral genome derived from the herpes virus, the genome allowing recombination essentially free of the host cell.
Public/Granted literature
- US20030165537A1 Vaccination against host cell-associated herpes viruses Public/Granted day:2003-09-04
Information query
